Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
25 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
134 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
58
58 articles ont été cités au moins 58fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
10 353
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
290
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
116
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Université Paris Cité · Hôpital Beaujon · Assistance Publique – Hôpitaux de Paris
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR)
2024ArticleDigestive and Liver Disease
Non-Redundant Combination of Hand-Crafted and Deep Learning Radiomics: Application to the Early Detection of Pancreatic Cancer
2023CongrèsCaPTion workshop (MICCAI)
Automatic detection of pancreatic lesions and main pancreatic duct dilatation on portal venous CT scans using deep learning
2023ArticleInvestigative Radiology
Learning shape distributions from large databases of healthy organs: applications to zero-shot and few-shot abnormal pancreas detection
2022CongrèsMedical Image Computing and Computer Assisted Interventions
Improving The Automatic Segmentation Of Elongated Organs Using Geometrical Priors
2022CongrèsIEEE International Symposium on Biomedical Imaging (ISBI 2022 )
Diffuse versus localized Caroli disease: a comparative MRCP study
2021ArticleAmerican Journal of Roentgenology
Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas
2020ArticleEuropean Journal of Radiology
Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study
2018ArticleAmerican Journal of Roentgenology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP SITE USLD PAUL BROUSSE
12 AV PAUL VAILLANT COUTURIER, 94804 VILLEJUIF CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Neuroendocrinology · 2017
Contrast-enhanced computed tomography (CT) of the neck-thorax-abdomen and pelvis, including 3-phase examination of the liver, constitutes the basic imaging for primary neuroendocrine tumor (NET) diagnosis, staging, surveillance, and therapy monitoring. CT characterization of lymph nodes is difficult because of inadequate size criteria (short axis diameter), and bone metastases are often missed. Contrast-enhanced magnetic resonance imaging (MRI) including diffusion-weighted imaging is preferred for the examination of the liver, pancreas, brain and bone. MRI may miss small lung metastases. MRI is less well suited than CT for the examination of extended body areas because of the longer examination procedure. Ultrasonography (US) frequently provides the initial diagnosis of liver metastases and contrast-enhanced US is excellent to characterize liver lesions that remain equivocal on CT/MRI. US is the method of choice to guide the biopsy needle for the histopathological NET diagnosis. US cannot visualize thoracic NET lesions for which CT-guided biopsy therefore is used. Endocopic US is the most sensitive method to diagnose pancreatic NETs, and additionally allows for biopsy. Intraoperative US facilitates lesion detection in the pancreas and liver. Somatostatin receptor imaging should be a part of the tumor staging, preoperative imaging and restaging, for which <sup>68</sup>Ga-DOTA-somatostatin analog PET/CT is recommended, which is vastly superior to somatostatin receptor scintigraphy, and facilitates the diagnosis of most types of NET lesions, for example lymph node metastases, bone metastases, liver metastases, peritoneal lesions, and primary small intestinal NETs. <sup>18</sup>FDG-PET/CT is better suited for G3 and high G2 NETs, which generally have higher glucose metabolism and less somatostatin receptor expression than low-grade NETs, and additionally provides prognostic information.
United European gastroenterology journal · 2020
The overall objective of these guidelines is to provide evidence‐based recommendations for the diagnosis and management of immunoglobulin G4 (IgG4)‐related digestive disease in adults and children. IgG4‐related digestive disease can be diagnosed only with a comprehensive work‐up that includes histology, organ morphology at imaging, serology, search for other organ involvement, and response to glucocorticoid treatment. Indications for treatment are symptomatic patients with obstructive jaundice, abdominal pain, posterior pancreatic pain, and involvement of extra‐pancreatic digestive organs, including IgG4‐related cholangitis. Treatment with glucocorticoids should be weight‐based and initiated at a dose of 0.6–0.8 mg/kg body weight/day orally (typical starting dose 30‐40 mg/day prednisone equivalent) for 1 month to induce remission and then be tapered within two additional months. Response to initial treatment should be assessed at week 2–4 with clinical, biochemical and morphological markers. Maintenance treatment with glucocorticoids should be considered in multi‐organ disease or history of relapse. If there is no change in disease activity and burden within 3 months, the diagnosis should be reconsidered. If the disease relapsed during the 3 months of treatment, immunosuppressive drugs should be added.
AJR. American journal of roentgenology · 2018
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
European journal of gastroenterology & hepatology · 2025 · Journal Article
Vullierme MP, Desterke C, Hillaire S, Parfait B, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2024 · Journal Article
Hautefeuille V, Williet N, Turpin A, Napoleon B, et al.
Best practice & research. Clinical endocrinology & metabolism · 2023 · Journal Article
Ronot M, Dioguardi Burgio M, Gregory J, Hentic O, et al.
Surgical endoscopy · 2023 · Journal Article
Martin A, Cros J, Vullierme MP, Dokmak S, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2022 · Letter
Maire F, Steuer N, Aubert A, Vullierme MP, et al.
European radiology · 2022 · Journal Article
Vullierme MP, Gregory J, Rebours V, Cros J, et al.
AJR. American journal of roentgenology · 2021 · Comparative Study
Lewin M, Desterke C, Guettier C, Valette PJ, et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2021 · Journal Article
Dokmak S, Tetart A, Aussilhou B, Choquet A, et al.
Journal of surgical case reports · 2020 · Case Reports
Hérin E, Sauvanet A, Cros J, Koulakian H, et al.
European journal of radiology · 2020 · Journal Article
Gregory J, Paisant A, Paulatto L, Raynaud L, et al.
World journal of gastroenterology · 2019 · Journal Article
Lorenzo D, Rebours V, Maire F, Palazzo M, et al.
Neuroendocrinology · 2019 · Journal Article
Capdevila J, Bodei L, Davies P, Gorbounova V, et al.
AJR. American journal of roentgenology · 2018 · Journal Article
Marion-Audibert AM, Vullierme MP, Ronot M, Mabrut JY, et al.
Surgery · 2017 · Journal Article
Birnbaum DJ, Gaujoux S, Berbis J, Dokmak S, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2015 · Journal Article
Rebours V, Cordova J, Couvelard A, Fabre M, et al.
Annals of surgery · 2015 · Journal Article
de Mestier L, Gaujoux S, Cros J, Hentic O, et al.
World journal of gastroenterology · 2015 · Case Reports
Dokmak S, Aussilhou B, Rasoaherinomenjanahary F, Sauvanet A, et al.
Radiology. Imaging cancer · 2023 · Journal Article
Assouline J, Cannella R, Porrello G, de Mestier L, et al.
Endocrine connections · 2017 · Journal Article
Zappa M, Hentic O, Vullierme MP, Lagadec M, et al.
Neuroendocrinology · 2017 · Journal Article
Sundin A, Arnold R, Baudin E, Cwikla JB, et al.
United European gastroenterology journal · 2016 · Journal Article
Robles EP, Maire F, Cros J, Vullierme MP, et al.
United European gastroenterology journal · 2019 · Comparative Study
Soliman H, Vullierme MP, Maire F, Hentic O, et al.
United European gastroenterology journal · 2017 · Journal Article
Laurent L, Vullierme MP, Rebours V, Maire F, et al.
United European gastroenterology journal · 2020 · Journal Article
Löhr JM, Beuers U, Vujasinovic M, Alvaro D, et al.
United European gastroenterology journal · 2019 · Journal Article
de Mestier L, Muller M, Cros J, Vullierme MP, et al.
Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score
BackgroundAbout 5% of pancreatic ductal adenocarcinomas are inherited due to a deleterious germline mutation detected in 20% or fewer families. Pancreatic screening in high-risk individuals is proposed to allow early sur
European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations
The overall objective of these guidelines is to provide evidence-based recommendations for the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in adults and children. IgG4-related digestive
Non-Redundant Combination of Hand-Crafted and Deep Learning Radiomics: Application to the Early Detection of Pancreatic Cancer
We address the problem of learning Deep Learning Radiomics (DLR) that are not redundant with Hand-Crafted Radiomics (HCR). To do so, we extract DLR features using a VAE while enforcing their independence with HCR feature
Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score
BackgroundAbout 5% of pancreatic ductal adenocarcinomas are inherited due to a deleterious germline mutation detected in 20% or fewer families. Pancreatic screening in high-risk individuals is proposed to allow early sur
European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations
The overall objective of these guidelines is to provide evidence-based recommendations for the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in adults and children. IgG4-related digestive
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).